OXFORD, England--(BUSINESS WIRE)--British techbio innovator Etcembly is coming out of stealth mode, kickstarting the next generation of immunotherapies with a pipeline of best-in-class T cell receptor ...

Real-World and Clinical Trial Validation of a Deep Learning Radiomic Biomarker for PD-(L)1 Immune Checkpoint Inhibitor Response in Advanced Non–Small Cell Lung Cancer Precision oncology in non–small ...

Beam Therapeutics' said the Food and Drug Administration granted generative medicine advanced therapy designation to its sickle cell disease treatment BEAM-101. The biotechnology company previously ...

—Researchers in Italy recently evaluated the ability of an artificial intelligence (AI) chatbot to recommend diagnostic and therapeutic approaches to care for patients with renal cell carcinoma (RCC).

Artificial intelligence (AI) has become the buzzword of our time. It’s a term that often conjures images of robots and self-learning machines, but in reality, AI is a broad umbrella with many distinct ...

An AI tool that can analyse abnormalities in the shape and form of blood cells, and with greater accuracy and reliability than human experts, could change the way conditions such as leukaemia are ...

What is the future of generative AI? Today’s generative AI trends and the risks AI can bring may shape the development of enterprise technology next year. Generative AI is as trendy as it has ever ...